Skip to content
Bending the Curve Trial by Trial
?

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients (EBMT Working Party Chronic Leukemia)

Needs review

Phase observationalN = 135

Population
135 patients with relapse after marrow transplantation: 84 CML, 23 AML, 22 ALL, 5 MDS, 1 polycythemia vera with osteomyelofibrosis.
Design
Series of 135 patients given donor lymphocyte transfusions for leukemia relapsing after marrow transplantation (the abstract does not say whether data were collected retrospectively or prospectively, or from a registry); response monitored including polymerase chain reaction for bcr/abl transcripts in CML.
Arms
  • Donor lymphocyte transfusion (experimental, n = 135): Transfusions of donor lymphocytes for relapse after marrow transplantation
People
Kolb HJ, European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia
Show the numbers
Results reported for Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients (EBMT Working Party Chronic Leukemia)
EndpointAnalysisDonor lymphocyte transfusionControlEffect
CRPatients with CML (84 treated); denominator for the percentage not stated in the abstractprimaryKolb 199573%—54 patients with CML reached complete remission, published as 73 percent. The abstract lists 84 patients with CML, but 54 of 84 is 64 percent, so the denominator behind 73 percent is not stated and could not be confirmed from the full text; do not recompute.
Results reported for Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients (EBMT Working Party Chronic Leukemia)
EndpointAnalysisDonor lymphocyte transfusionControlEffect
CRPatients with CML (84 treated); denominator for the percentage not stated in the abstractprimaryKolb 199573%—54 patients with CML reached complete remission, published as 73 percent. The abstract lists 84 patients with CML, but 54 of 84 is 64 percent, so the denominator behind 73 percent is not stated and could not be confirmed from the full text; do not recompute.
Primary publication: Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995;86(5):2041-50. PubMed

Appears in

Sources

  1. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995;86(5):2041-50.

    PubMed